Integrative genomic, epigenetic and functional studies in diabetic kidney disease
Integrative genomic, epigenetic and functional studies in diabetic kidney disease
批准号:
9029513
负责人:
JOSE CARLOS FLOREZ
金额:
$84.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-12-23 至 2019-11-30
关键词:
AddressAmputationAreaBiologicalBiological MarkersBiological ModelsBiological ProcessBiologyBiopsyBlindnessBloodCandidate Disease GeneCell modelChronic Kidney FailureCodeCollaborationsComplementComplicationComplications of Diabetes MellitusDNA MethylationDNA SequenceDataData SetDevelopmentDiabetes MellitusDiabetic NephropathyDiseaseEnd stage renal failureEpigenetic ProcessFrequenciesFunctional disorderFundingFunding MechanismsGene Expression ProfilingGene TargetingGenesGeneticGenetic studyGenomicsGuide preventionHealth Care CostsHeart DiseasesHeterogeneityHyperglycemiaIndividualInheritedInstitutesInsulin-Dependent Diabetes MellitusInterdisciplinary StudyInternationalInvestigationIrelandKidneyKidney DiseasesKidney FailureKnowledgeLettersMeta-AnalysisMethodsMethylationMicrovascular DysfunctionModelingMolecularNorthern IrelandOrganParticipantPathogenesisPathway interactionsPatientsPhenotypePlayPositioning AttributePreventionPrevention strategyPreventive measureProcessPublic HealthPublishingRegulatory ElementRenal functionResearchResourcesRiskRisk FactorsRoleSample SizeSamplingSecondary toSeveritiesStrokeTestingTranslatingUniversitiesUntranslated RNAValidationVariantbasediabeticexomeexome sequencingfollow-upgenetic analysisgenetic approachgenetic associationgenetic risk factorgenetic variantgenome wide association studygenomic dataglycemic controlhuman dataimprovedinsightmacrovascular diseasemortalitymultidisciplinarynovelpotential biomarkerpublic health relevancerare varianttrait
中文摘要
英文摘要
DESCRIPTION (provided by applicant): Diabetic kidney disease (DKD) is a leading cause of kidney failure and end stage renal disease, and brings a substantial burden of early mortality and accompanying health care costs. Genetic factors contribute to the risk of DKD. If we could identify these genetic factors, we could better understand the mechanisms by which DKD occurs, and thereby accelerate the development of better therapies. We established the GENIE consortium, a collaboration between Queen's University Belfast, University of Dublin, University of Helsinki, and the Broad Institute. Together, we completed the largest genetic study to date of DKD, and successfully identified the first two robust genetic risk factors for DKD. In a separately
funded genetic study, we are collaborating with additional groups to extend our efforts and encompass larger samples. To better understand the underlying biology and pathophysiology of DKD, we propose to complement and build on our past and ongoing genetic studies in several critical ways. We will leverage a co-funding mechanism between Ireland, Northern Ireland and the US to carry out a multidisciplinary investigation of DKD. We will assemble and jointly analyze all available genetic data pertinent to DKD, to begin the process of discovering rarer variants with stronger effects on DKD. We will also generate DNA methylation data in kidney and blood, and in patients with and without DKD, and also expression data in samples relevant to DKD. We use a novel and powerful method to integrate the genetic, epigenetic and genomic data to generate hypotheses about the biological causes of DKD, and test these hypotheses with further genetic studies (sequencing in a large follow-up sample) and with functional studies in models of DKD. This international, multidisciplinary collaboration will build on genetic discoveries to help decipher the underlying biology and pathophysiology of DKD and thereby guide the prevention and treatment of this important disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A functional genomics pipeline for genetic discovery in diabetic kidney disease
-
批准号:10673703
-
项目类别:
-
资助金额:$63.15万
-
财政年份:2022
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
A functional genomics pipeline for genetic discovery in diabetic kidney disease
-
批准号:10418927
-
项目类别:
-
资助金额:$71.86万
-
财政年份:2022
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Pharmacogenetic discovery in the GRADE comparative effectiveness type 2 diabetes clinical trial
-
批准号:10378153
-
项目类别:
-
资助金额:$65.23万
-
财政年份:2021
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Mentoring Investigators on the Clinical Translation of Cardiometabolic Genetic Discoveries
-
批准号:10677868
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2021
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Mentoring Investigators on the Clinical Translation of Cardiometabolic Genetic Discoveries
-
批准号:10215725
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2021
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Mentoring Investigators on the Clinical Translation of Cardiometabolic Genetic Discoveries
-
批准号:10465073
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2021
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Pharmacogenetic discovery in the GRADE comparative effectiveness type 2 diabetes clinical trial
-
批准号:10211219
-
项目类别:
-
资助金额:$70.49万
-
财政年份:2021
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Pharmacogenetic discovery in the GRADE comparative effectiveness type 2 diabetes clinical trial
-
批准号:10589095
-
项目类别:
-
资助金额:$65.07万
-
财政年份:2021
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Bridging the gap between type 2 diabetes GWAS and therapeutic targets
-
批准号:10242210
-
项目类别:
-
资助金额:$194.89万
-
财政年份:2020
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Bridging the gap between type 2 diabetes GWAS and therapeutic targets
-
批准号:10064781
-
项目类别:
-
资助金额:$202.53万
-
财政年份:2020
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus
-
批准号:10364884
-
项目类别:
-
资助金额:$16.39万
-
财政年份:2018
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Harvard Training Program in Bioinformatics Applied to Diabetes, Obesity and Metabolism.
-
批准号:10251889
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2017
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Harvard Training Program in Bioinformatics Applied to Diabetes, Obesity and Metabolism.
-
批准号:10005313
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2017
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Mentoring Investigators on the Clinical Translation of Genetic Discoveries in Type 2 Diabetes
-
批准号:9334188
-
项目类别:
-
资助金额:$16.24万
-
财政年份:2016
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Mentoring Investigators on the Clinical Translation of Genetic Discoveries in Type 2 Diabetes
-
批准号:9752582
-
项目类别:
-
资助金额:$16.24万
-
财政年份:2016
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Mentoring Investigators on the Clinical Translation of Genetic Discoveries in Type 2 Diabetes
-
批准号:9165063
-
项目类别:
-
资助金额:$16.24万
-
财政年份:2016
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3
-
批准号:10454833
-
项目类别:
-
资助金额:$58.59万
-
财政年份:2015
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Equipment Supplement for Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3
-
批准号:10797707
-
项目类别:
-
资助金额:$2.94万
-
财政年份:2015
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Proposal for the AMP T2D-GENES Data Coordination Center and Web Portal
-
批准号:10006919
-
项目类别:
-
资助金额:$63.1万
-
财政年份:2015
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
Proposal for the AMP T2D-GENES Data Coordination Center and Web Portal
-
批准号:9547034
-
项目类别:
-
资助金额:$120.0万
-
财政年份:2015
-
负责人:JOSE CARLOS FLOREZ
-
依托单位:
海外基金